Cargando…

Cranial autonomic symptoms and response to monoclonal antibodies targeting the Calcitonin gene-related peptide pathway: A real-world study

OBJECTIVE: Cranial autonomic symptoms (CAS), including conjunctival injection, tearing, nasal congestion or rhinorrhea, eyelid edema, miosis or ptosis, and forehead or facial sweating ipsilateral to headache, are often reported by patients with migraine during headache attacks. CAS is a consequence...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Matteis, Eleonora, Caponnetto, Valeria, Casalena, Alfonsina, Frattale, Ilaria, Gabriele, Amleto, Affaitati, Giannapia, Giamberardino, Maria Adele, Maddestra, Maurizio, Viola, Stefano, Pistoia, Francesca, Sacco, Simona, Ornello, Raffaele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538972/ https://www.ncbi.nlm.nih.gov/pubmed/36212640 http://dx.doi.org/10.3389/fneur.2022.973226

Ejemplares similares

Conversion from chronic to episodic migraine in patients treated with erenumab: real-life data from an Italian region
por: Ornello, Raffaele, et al.
Publicado: (2020)

Association between response to triptans and response to erenumab: real-life data
por: Frattale, Ilaria, et al.
Publicado: (2021)

Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy
por: Ornello, Raffaele, et al.
Publicado: (2020)

Menstrual Headache in Women with Chronic Migraine Treated with Erenumab: An Observational Case Series
por: Ornello, Raffaele, et al.
Publicado: (2021)

Calcitonin gene-related peptide receptor as a novel target for the management of people with episodic migraine: current evidence and safety profile of erenumab
por: Giamberardino, Maria Adele, et al.
Publicado: (2017)

How to integrate monoclonal antibodies targeting the calcitonin gene-related peptide or its receptor in daily clinical practice
por: Tiseo, Cindy, et al.
Publicado: (2019)

Acute and Preventive Management of Migraine during Menstruation and Menopause
por: Ornello, Raffaele, et al.
Publicado: (2021)

Effects of PDE5 Inhibitors and sGC Stimulators in a Rat Model of Artificial Ureteral Calculosis
por: Sandner, Peter, et al.
Publicado: (2015)

Patterns of Migraine in Postmenopausal Women: A Systematic Review
por: Ornello, Raffaele, et al.
Publicado: (2021)

Different effects of air microembolism through patent foramen ovale in patients with migraine: A quantitative electroencephalogram case series
por: Ornello, Raffaele, et al.
Publicado: (2022)

Laparoscopic Cholecystectomy for Gallbladder Calculosis in Fibromyalgia Patients: Impact on Musculoskeletal Pain, Somatic Hyperalgesia and Central Sensitization
por: Costantini, Raffaele, et al.
Publicado: (2016)

Effects of topical vs injection treatment of cervical myofascial trigger points on headache symptoms in migraine patients: a retrospective analysis
por: Affaitati, Giannapia, et al.
Publicado: (2018)

Effectiveness of Transcranial Direct Current Stimulation and Monoclonal Antibodies Acting on the CGRP as a Combined Treatment for Migraine (TACTIC): Protocol for a Randomized, Double-Blind, Sham-Controlled Trial
por: Ornello, Raffaele, et al.
Publicado: (2022)

Gender Differences in 3-Month Outcomes of Erenumab Treatment—Study on Efficacy and Safety of Treatment With Erenumab in Men
por: Ornello, Raffaele, et al.
Publicado: (2021)

Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study
por: Ornello, Raffaele, et al.
Publicado: (2022)

O032. Associations between any headache and obesity: results from a systematic review and meta-analysis of observational studies
por: Degan, Diana, et al.
Publicado: (2015)

O050. Chronic daily headache and body mass index: a meta-analysis of observational studies
por: Tiseo, Cindy, et al.
Publicado: (2015)

The appropriate dosing of erenumab for migraine prevention after multiple preventive treatment failures: a critical appraisal
por: Ornello, Raffaele, et al.
Publicado: (2019)

P003. NSAIDs for symptomatic treatment of headache
por: Affaitati, Giannapia, et al.
Publicado: (2015)

Migraine Prevention with Erenumab: Focus on Patient Selection, Perspectives and Outcomes
por: De Matteis, Eleonora, et al.
Publicado: (2022)

New insights into the cardiovascular risk of migraine and the role of white matter hyperintensities: is gold all that glitters?
por: Tana, Claudio, et al.
Publicado: (2013)

Sustained response to onabotulinumtoxin A in patients with chronic migraine: real-life data
por: Ornello, Raffaele, et al.
Publicado: (2020)

Impact of migraine on fibromyalgia symptoms
por: Giamberardino, Maria Adele, et al.
Publicado: (2016)

Behavioral and psychological factors in individuals with migraine without psychiatric comorbidities
por: Pistoia, Francesca, et al.
Publicado: (2022)

Acute Medication Use in Patients With Migraine Treated With Monoclonal Antibodies Acting on the CGRP Pathway: Results From a Multicenter Study and Proposal of a New Index
por: Sette, Lucia, et al.
Publicado: (2022)

Which is the best transcranial direct current stimulation protocol for migraine prevention? A systematic review and critical appraisal of randomized controlled trials
por: Ornello, Raffaele, et al.
Publicado: (2021)

Migraine and hemorrhagic stroke: data from general practice
por: Ornello, Raffaele, et al.
Publicado: (2015)

Symptoms of gait and coordination impairment in a patient with COVID-19 interstitial pneumonia
por: Pistoia, Francesca, et al.
Publicado: (2021)

European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update
por: Sacco, Simona, et al.
Publicado: (2022)

Peripheral vascular dysfunction in migraine: a review
por: Sacco, Simona, et al.
Publicado: (2013)

Migraine and body mass index categories: a systematic review and meta-analysis of observational studies
por: Ornello, Raffaele, et al.
Publicado: (2015)

EHMTI-0392. Migraine and risk of ischemic heart disease: a systematic review and meta-analysis of observational studies
por: Sacco, S, et al.
Publicado: (2014)

O059. Predictors of response to botulinum toxin for the treatment of chronic migraine: data from a Headache Center
por: Ornello, Raffaele, et al.
Publicado: (2015)

Investigating the Effects of COVID-19 Quarantine in Migraine: An Observational Cross-Sectional Study From the Italian National Headache Registry (RICe)
por: Delussi, Marianna, et al.
Publicado: (2020)

Migraine in menopausal women: a systematic review
por: Ripa, Patrizia, et al.
Publicado: (2015)

Applying a biopsychosocial model to migraine: rationale and clinical implications
por: Rosignoli, Chiara, et al.
Publicado: (2022)

Migraine during COVID-19: Data from Second Wave Pandemic in an Italian Cohort
por: Gentile, Eleonora, et al.
Publicado: (2021)

The Comorbidities Coma Scale (CoCoS): Psychometric Properties and Clinical Usefulness in Patients With Disorders of Consciousness
por: Pistoia, Francesca, et al.
Publicado: (2019)

Translation and Transcultural Adaptation of the Wessex Head Injury Matrix, Italian Version: A Preliminary Report
por: Pistoia, Francesca, et al.
Publicado: (2021)

Chronic Migraine and Medication Overuse Headache Worsening After OnabotulinumtoxinA Withdrawn Due to the Severe Acute Respiratory Syndrome-Coronavirus-2 Pandemic
por: Baraldi, Carlo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gmk2cd8jotvj760cepoan3vd9b